Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The Wada (intracarotid amobarbital) test is done to localize speech and memory functions in some candidates for epilepsy surgery. The internal carotid vascular distribution of half of the brain is put to sleep through injection of a quick-acting barbiturate into the internal carotid artery (via a catheter placed in the femoral vein at the groin).
During the next 5-15 minutes, speech and memory are tested. Surgery can be performed on the temporal lobe of the speech-dominant side, but not as much brain can safely be removed as on the non-dominant side. Global amnesia after injecting one internal carotid artery is a danger signal for surgery, because this result suggests that there may be severe memory problems after the operation. Not every surgical candidate requires a Wada test.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.